Published in Oncogene on October 29, 2001
PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. J Virol (2006) 3.03
Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev (2012) 2.92
Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1. J Virol (2004) 2.69
PML nuclear bodies. Cold Spring Harb Perspect Biol (2010) 2.44
Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections. J Virol (2006) 2.41
The degradation of promyelocytic leukemia and Sp100 proteins by herpes simplex virus 1 is mediated by the ubiquitin-conjugating enzyme UbcH5a. Proc Natl Acad Sci U S A (2003) 2.12
Daxx-mediated accumulation of human cytomegalovirus tegument protein pp71 at ND10 facilitates initiation of viral infection at these nuclear domains. J Virol (2002) 1.81
Promyelocytic leukemia nuclear bodies associate with transcriptionally active genomic regions. J Cell Biol (2004) 1.74
Relocalization of the Mre11-Rad50-Nbs1 complex by the adenovirus E4 ORF3 protein is required for viral replication. J Virol (2005) 1.63
Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infection. J Virol (2007) 1.61
Deconstructing PML-induced premature senescence. EMBO J (2002) 1.56
Nuclear body movement is determined by chromatin accessibility and dynamics. Proc Natl Acad Sci U S A (2004) 1.52
Recruitment of herpes simplex virus type 1 transcriptional regulatory protein ICP4 into foci juxtaposed to ND10 in live, infected cells. J Virol (2003) 1.50
Promyelocytic leukemia isoform IV confers resistance to encephalomyocarditis virus via the sequestration of 3D polymerase in nuclear bodies. J Virol (2011) 1.49
Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of the MRE11/RAD50/NBS1 complex. Mol Cell Biol (2005) 1.44
The two functions of herpes simplex virus 1 ICP0, inhibition of silencing by the CoREST/REST/HDAC complex and degradation of PML, are executed in tandem. J Virol (2008) 1.40
A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics. Int J Biol Sci (2010) 1.38
PML isoforms I and II participate in PML-dependent restriction of HSV-1 replication. J Cell Sci (2010) 1.35
Serotype-specific reorganization of the Mre11 complex by adenoviral E4orf3 proteins. J Virol (2005) 1.33
Cross talk between PML and p53 during poliovirus infection: implications for antiviral defense. J Virol (2006) 1.30
FLASH links the CD95 signaling pathway to the cell nucleus and nuclear bodies. EMBO J (2007) 1.26
Interplay between viruses and host sumoylation pathways. Nat Rev Microbiol (2013) 1.26
Recruitment of human cyclin T1 to nuclear bodies through direct interaction with the PML protein. EMBO J (2003) 1.26
Protein inhibitor of activated STAT Y (PIASy) and a splice variant lacking exon 6 enhance sumoylation but are not essential for embryogenesis and adult life. Mol Cell Biol (2004) 1.24
Differential role of Sp100 isoforms in interferon-mediated repression of herpes simplex virus type 1 immediate-early protein expression. J Virol (2006) 1.24
Proteasome-dependent degradation of Daxx by the viral E1B-55K protein in human adenovirus-infected cells. J Virol (2010) 1.23
Cellular proteins PML and Daxx mediate an innate antiviral defense antagonized by the adenovirus E4 ORF3 protein. J Virol (2008) 1.22
Replication and partitioning of papillomavirus genomes. Adv Virus Res (2008) 1.21
Interaction of the adenovirus type 5 E4 Orf3 protein with promyelocytic leukemia protein isoform II is required for ND10 disruption. J Virol (2006) 1.21
The checkpoints of viral gene expression in productive and latent infection: the role of the HDAC/CoREST/LSD1/REST repressor complex. J Virol (2011) 1.20
Gamma interferon and cadmium treatments modulate eukaryotic initiation factor 4E-dependent mRNA transport of cyclin D1 in a PML-dependent manner. Mol Cell Biol (2002) 1.17
Herpes simplex virus 1 ubiquitin ligase ICP0 interacts with PML isoform I and induces its SUMO-independent degradation. J Virol (2012) 1.16
Determination of minimum herpes simplex virus type 1 components necessary to localize transcriptionally active DNA to ND10. J Virol (2003) 1.15
Sumoylation of the transcription factor NFATc1 leads to its subnuclear relocalization and interleukin-2 repression by histone deacetylase. J Biol Chem (2009) 1.13
PML clastosomes prevent nuclear accumulation of mutant ataxin-7 and other polyglutamine proteins. J Cell Biol (2006) 1.12
Oligomerization of ICP4 and rearrangement of heat shock proteins may be important for herpes simplex virus type 1 prereplicative site formation. J Virol (2008) 1.10
Control of viral infectivity by tripartite motif proteins. Hum Gene Ther (2005) 1.10
Murine gammaherpesvirus 68 open reading frame 75c tegument protein induces the degradation of PML and is essential for production of infectious virus. J Virol (2008) 1.10
Phosphorylation site mutations affect herpes simplex virus type 1 ICP0 function. J Virol (2005) 1.08
Visualization by live-cell microscopy of disruption of ND10 during herpes simplex virus type 1 infection. J Virol (2004) 1.06
Evidence for a dual antiviral role of the major nuclear domain 10 component Sp100 during the immediate-early and late phases of the human cytomegalovirus replication cycle. J Virol (2011) 1.03
Interplay between Herpesvirus Infection and Host Defense by PML Nuclear Bodies. Viruses (2009) 1.03
Assembly dynamics of PML nuclear bodies in living cells. PMC Biophys (2010) 1.02
Role of SUMO in RNF4-mediated promyelocytic leukemia protein (PML) degradation: sumoylation of PML and phospho-switch control of its SUMO binding domain dissected in living cells. J Biol Chem (2009) 1.00
A novel protein, Luman/CREB3 recruitment factor, inhibits Luman activation of the unfolded protein response. Mol Cell Biol (2008) 1.00
Gene expression in the third dimension: the ECM-nucleus connection. J Mammary Gland Biol Neoplasia (2010) 0.99
Recruitment of human cytomegalovirus immediate-early 2 protein onto parental viral genomes in association with ND10 in live-infected cells. J Virol (2007) 0.99
Promyelocytic leukemia-nuclear body proteins: herpesvirus enemies, accomplices, or both? Future Virol (2008) 0.98
Progressive multifocal leukoencephalopathy and promyelocytic leukemia nuclear bodies: a review of clinical, neuropathological, and virological aspects of JC virus-induced demyelinating disease. Acta Neuropathol (2010) 0.98
Mouse cytomegalovirus early M112/113 proteins control the repressive effect of IE3 on the major immediate-early promoter. J Virol (2005) 0.98
PML promotes MHC class II gene expression by stabilizing the class II transactivator. J Cell Biol (2012) 0.95
Resistance to rabies virus infection conferred by the PMLIV isoform. J Virol (2010) 0.94
Sumoylation of p45/NF-E2: nuclear positioning and transcriptional activation of the mammalian beta-like globin gene locus. Mol Cell Biol (2005) 0.93
Transcriptional repression and cell death induced by nuclear aggregates of non-polyglutamine protein. Neurobiol Dis (2005) 0.93
Trafficking of some old world primate TRIM5α proteins through the nucleus. Retrovirology (2011) 0.92
Herpes simplex virus type 1 ICP0 protein mediates activation of adeno-associated virus type 2 rep gene expression from a latent integrated form. J Virol (2004) 0.92
Virus-induced aggregates in infected cells. Viruses (2012) 0.91
The differential requirement for cyclin-dependent kinase activities distinguishes two functions of herpes simplex virus type 1 ICP0. J Virol (2003) 0.91
Herpes simplex virus type 1 ICP0 phosphorylation mutants impair the E3 ubiquitin ligase activity of ICP0 in a cell type-dependent manner. J Virol (2008) 0.90
Distribution of different phosphorylated forms of RNA polymerase II in relation to Cajal and PML bodies in human cells: an ultrastructural study. Histochem Cell Biol (2005) 0.90
Herpes simplex virus is equipped with RNA- and protein-based mechanisms to repress expression of ATRX, an effector of intrinsic immunity. J Virol (2012) 0.88
SUMOylation promotes PML degradation during encephalomyocarditis virus infection. J Virol (2010) 0.87
The adenoviral oncogene E1A-13S interacts with a specific isoform of the tumor suppressor PML to enhance viral transcription. J Virol (2012) 0.87
Promyelocytic leukemia protein (PML) regulates endothelial cell network formation and migration in response to tumor necrosis factor α (TNFα) and interferon α (IFNα). J Biol Chem (2012) 0.87
The jmjN and jmjC domains of the yeast zinc finger protein Gis1 interact with 19 proteins involved in transcription, sumoylation and DNA repair. Mol Genet Genomics (2006) 0.87
Sp2 localizes to subnuclear foci associated with the nuclear matrix. Mol Biol Cell (2006) 0.87
Influence of ND10 components on epigenetic determinants of early KSHV latency establishment. PLoS Pathog (2014) 0.86
SUMOylation of the Forkhead transcription factor FOXL2 promotes its stabilization/activation through transient recruitment to PML bodies. PLoS One (2011) 0.86
The potential link between PML NBs and ICP0 in regulating lytic and latent infection of HSV-1. Protein Cell (2012) 0.85
Puromycin-based vectors promote a ROS-dependent recruitment of PML to nuclear inclusions enriched with HSP70 and Proteasomes. BMC Cell Biol (2009) 0.85
Dualistic function of Daxx at centromeric and pericentromeric heterochromatin in normal and stress conditions. Nucleus (2012) 0.84
Sumoylation of the novel protein hRIP{beta} is involved in replication protein A deposition in PML nuclear bodies. Mol Cell Biol (2005) 0.84
Microarray analysis revealing common and distinct functions of promyelocytic leukemia protein (PML) and tumor necrosis factor alpha (TNFα) signaling in endothelial cells. BMC Genomics (2012) 0.83
Telomeric DNA mediates de novo PML body formation. Mol Biol Cell (2009) 0.83
PML isoforms in response to arsenic: high-resolution analysis of PML body structure and degradation. J Cell Sci (2013) 0.83
Epstein-Barr virus LF2 protein regulates viral replication by altering Rta subcellular localization. J Virol (2010) 0.82
Murine gammaherpesvirus 68 ORF75c contains ubiquitin E3 ligase activity and requires PML SUMOylation but not other known cellular PML regulators, CK2 and E6AP, to mediate PML degradation. Virology (2013) 0.82
Trafficking of the transcription factor Nrf2 to promyelocytic leukemia-nuclear bodies: implications for degradation of NRF2 in the nucleus. J Biol Chem (2013) 0.81
PML(NLS(-)) inhibits cell apoptosis and promotes proliferation in HL-60 cells. Int J Med Sci (2013) 0.81
Disruption of host antiviral resistances by gammaherpesvirus tegument proteins with homology to the FGARAT purine biosynthesis enzyme. Curr Opin Virol (2015) 0.81
Nuclear domain 10 of the viral aspect. World J Virol (2013) 0.80
Human cytomegalovirus tropism for mucosal myeloid dendritic cells. Rev Med Virol (2014) 0.80
Promyelocytic leukemia protein modulates establishment and maintenance of latent gammaherpesvirus infection in peritoneal cells. J Virol (2013) 0.80
Aggresome formation by the adenoviral protein E1B55K is not conserved among adenovirus species and is not required for efficient degradation of nuclear substrates. J Virol (2013) 0.80
PML nuclear bodies: assembly and oxidative stress-sensitive sumoylation. Nucleus (2014) 0.79
In human pachytene spermatocytes, SUMO protein is restricted to the constitutive heterochromatin. Chromosome Res (2008) 0.79
Regulation of Sp100A subnuclear localization and transcriptional function by EBNA-LP and interferon. J Interferon Cytokine Res (2008) 0.78
SP140L, an Evolutionarily Recent Member of the SP100 Family, Is an Autoantigen in Primary Biliary Cirrhosis. J Immunol Res (2015) 0.77
Shigella infection interferes with SUMOylation and increases PML-NB number. PLoS One (2015) 0.76
Viral FGARAT Homolog ORF75 of Rhesus Monkey Rhadinovirus Effects Proteasomal Degradation of the ND10 Components SP100 and PML. J Virol (2016) 0.76
Incoming human papillomavirus 16 genome is lost in PML protein-deficient HaCaT keratinocytes. Cell Microbiol (2016) 0.75
Regulation of Neuronal Protein Trafficking and Translocation by SUMOylation. Biomolecules (2012) 0.75
Using antiubiquitin antibodies to probe the ubiquitination state within rhTRIM5α cytoplasmic bodies. AIDS Res Hum Retroviruses (2013) 0.75
On the origin of non-membrane-bound organelles, and their physiological function. J Theor Biol (2017) 0.75
Gene Knockout Shows That PML (TRIM19) Does Not Restrict the Early Stages of HIV-1 Infection in Human Cell Lines. mSphere (2017) 0.75
Tripartite Motif-Containing Protein 22 Interacts with Class II Transactivator and Orchestrates Its Recruitment in Nuclear Bodies Containing TRIM19/PML and Cyclin T1. Front Immunol (2017) 0.75
A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell (1994) 6.52
PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol (1999) 5.83
BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene (1998) 4.88
HSV-1 IE protein Vmw110 causes redistribution of PML. EMBO J (1994) 4.61
The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition. J Cell Biol (1996) 3.91
Identification of a novel nuclear domain. J Cell Biol (1991) 3.91
The nuclear and the cytoplasmic pore complex: structure, dynamics, distribution, and evolution. Int Rev Cytol Suppl (1977) 3.81
Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev (1996) 3.63
Time sequence of nuclear pore formation in phytohemagglutinin-stimulated lymphocytes and in HeLa cells during the cell cycle. J Cell Biol (1972) 3.03
Human cytomegalovirus immediate early interaction with host nuclear structures: definition of an immediate transcript environment. J Cell Biol (1997) 2.70
The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1. Exp Cell Res (1996) 2.69
Differential regulation of sentrinized proteins by a novel sentrin-specific protease. J Biol Chem (2000) 2.34
Golgi-melanosome relationship in human melanoma in vitro. J Ultrastruct Res (1969) 1.99
Molecular characterization of NDP52, a novel protein of the nuclear domain 10, which is redistributed upon virus infection and interferon treatment. J Cell Biol (1995) 1.92
Formation and distribution of nuclear pore complexes in interphase. J Cell Biol (1971) 1.78
On the possible function of coated vesicles in melanogenesis of the regenerating fowl feather. J Cell Biol (1971) 1.68
Membrane fusion as a mechanism of simian virus 40 entry into different cellular compartments. J Virol (1978) 1.62
Nuclear ribonucleoprotein release and nucleoside triphosphatase activity are inhibited by antibodies directed against one nuclear matrix glycoprotein. Proc Natl Acad Sci U S A (1983) 1.60
Structure and formation of pores in fenestrated capillaries. J Ultrastruct Res (1971) 1.58
Accumulation and intranuclear distribution of unintegrated human immunodeficiency virus type 1 DNA. J Virol (2001) 1.53
The intranuclear localization of two DNA-dependent RNA polymerase activities. Proc Natl Acad Sci U S A (1967) 1.48
Lytic but not latent replication of epstein-barr virus is associated with PML and induces sequential release of nuclear domain 10 proteins. J Virol (2000) 1.47
Replication but not transcription of simian virus 40 DNA is dependent on nuclear domain 10. J Virol (2000) 1.46
Are ACA and Scl 70 antibodies mutually exclusive? Br J Dermatol (1990) 1.44
Autoantibodies to nuclear lamin C in the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Arthritis Rheum (1992) 1.41
Nuclear lamins and peripheral nuclear antigens during fertilization and embryogenesis in mice and sea urchins. Proc Natl Acad Sci U S A (1985) 1.36
Quantitative determination of nuclear pore complexes in cycling cells with differing DNA content. J Cell Biol (1977) 1.33
Primary melanoma cells of the vertical growth phase: similarities to metastatic cells. J Natl Cancer Inst (1985) 1.30
Nuclear envelope proteins from Spisula solidissima germinal vesicles. Exp Cell Res (1980) 1.26
Mononuclear cellular infiltrates in clinically involved skin from patients with systemic sclerosis of recent onset predominantly consist of monocytes/macrophages. Pathobiology (1995) 1.25
On the octagonality of the nuclear pore complex. J Cell Biol (1971) 1.22
Pore patterns on nuclear membranes. Exp Cell Res (1974) 1.21
The golgi apparatus during mitosis in human melanoma cells in vitro. Cancer Res (1970) 1.21
Nuclear pore complexes. Elimination and reconstruction during mitosis. J Cell Biol (1977) 1.17
On the relationship between the Golgi apparatus and annulate lamellae. J Ultrastruct Res (1970) 1.12
Receptor utilization by reovirus type 3: distinct binding sites on thymoma and fibroblast cell lines result in differential compartmentalization of virions. Microb Pathog (1992) 1.07
A novel nuclear substructure, ND10: distribution in normal and neoplastic human tissues. Int J Mol Med (1998) 1.05
A novel antinuclear antibody associated with a lupus-like paraneoplastic syndrome. Ann Intern Med (1988) 1.05
Hepatitis delta virus replication generates complexes of large hepatitis delta antigen and antigenomic RNA that affiliate with and alter nuclear domain 10. J Virol (2000) 1.04
The major 67 000 molecular weight protein of the clam oocyte nuclear envelope is lamin-like. J Cell Sci (1984) 1.04
Topoisomerase I identified by scleroderma 70 antisera: enrichment of topoisomerase I at the centromere in mouse mitotic cells before anaphase. Proc Natl Acad Sci U S A (1986) 1.03
Regulation of c-met expression by transcription repressor Daxx. Oncogene (2007) 0.98
Ultrastructural comparison of two human malignant melanoma cell lines. Cancer Res (1970) 0.98
Evidence for separate ND10-binding and homo-oligomerization domains of Sp100. J Cell Sci (2001) 0.96
Histologic and electron microscopic characterization of the antiperinuclear factor antigen. Arthritis Rheum (1990) 0.96
Effect of metabolic inhibitors on nuclear pore formation during the HeLa S3 cell cycle. J Cell Biol (1973) 0.95
Fibrils attached to the nuclear pore prevent egress of SV40 particles from the infected nucleus. J Cell Biol (1976) 0.95
Nucleotide sequence of a cDNA clone for mouse pro alpha 1(I) collagen protein. Gene (1985) 0.92
A nucleolar auto-antigen is part of a major chromosomal surface component. Chromosoma (1990) 0.90
Investigation of the determinants of nuclear pore number. Cytogenet Cell Genet (1980) 0.89
Non-apoptotic chromosome condensation induced by stress: delineation of interchromosomal spaces. Chromosoma (2000) 0.89
Screening cDNA expression libraries with monoclonal and polyclonal antibodies using an amplified biotin-avidin-peroxidase technique. Anal Biochem (1986) 0.88
Identification and redistribution of lamins during nuclear differentiation in mouse spermatogenesis. Dev Biol (1986) 0.87
Ultrastructure of pore complexes of annulate lamellae. J Cell Biol (1970) 0.87
Isolation and characterization of microvascular endothelial cells from the adult human dermis and from skin biopsies of patients with systemic sclerosis. Lab Invest (1994) 0.85
Antikinetochore and antitopoisomerase I antibodies in systemic scleroderma: comparative study using immunoblotted recombinant antigens, immunofluorescence, and double immunodiffusion. Arch Dermatol Res (1990) 0.85
Nuclear lamin antigens are developmentally regulated during porcine and bovine embryogenesis. Biol Reprod (1989) 0.82
Determination of newly synthesized and phosphorylated nuclear proteins in mass-isolated germinal vesicle of Spisula solidissima. Exp Cell Res (1980) 0.82
Cytochemical studies on the relation of nucleoside triphosphatase activity to ribonucleoproteins in isolated rat liver nuclei. J Histochem Cytochem (1980) 0.80
The cellular RING finger protein PML is not a functional counterpart of the herpes simplex virus type 1 RING finger protein Vmw110. J Gen Virol (1995) 0.80
Transient expression of full-length and truncated forms of the human nerve growth factor receptor. Brain Res Mol Brain Res (1990) 0.80
Time sequence and morphological evaluations of cells fused by polyethylene glycol 6000(1). In Vitro (1976) 0.80
Transplantation of systemic sclerosis (SSc) skin grafts into severe combined immunodeficient mice: increased presence of SSc leukocytes in SSc skin grafts and autoantibody production following autologous leukocyte transfer. Pathobiology (1996) 0.79
Annulate lamellae and single pore complexes in normal, SV40-transformed and tumor cells in vitro. A semiquantitative analysis. Exp Cell Res (1977) 0.79
Localization of a major nuclear envelope protein by differential solubilization. Exp Cell Res (1983) 0.78
[Monoclonal antibodies against protein Daxx and its localization in nuclear domains 10]. Tsitologiia (2001) 0.78
The presence of intranuclear annulate lamellae shortly after mitosis in human melanoma cells in vitro. J Ultrastruct Res (1970) 0.78
Detection of type A oncornavirus-like structures in chicken embryo cells after infection with Rous sarcoma virus. J Virol (1975) 0.78
The nerve growth factor receptor in normal and transformed neural crest cells. Ann N Y Acad Sci (1986) 0.77
Characterization of a major nucleoplasmin-like germinal vesicle protein which is rapidly phosphorylated before germinal vesicle breakdown in Spisula solidissima. Dev Biol (1994) 0.77
Characteristic immunolocalization of Ku protein as nuclear matrix. Hybridoma (1998) 0.77
Detection of nuclear lamin B epitopes in oocyte nuclei from mice, sea urchins, and clams using a human autoimmune serum. Dev Biol (1987) 0.77
The expression of nuclear lamin A and C epitopes is regulated by the developmental stage of the cytoplasm in mouse oocytes or embryos. J Exp Zool (1991) 0.75
Cytoplasmic modification of the nuclear lamina during pronuclear-like transformation of mouse blastomere nuclei. Mech Dev (1991) 0.75
Thymidine incorporation by annulate lamellae of rabbit zygoes. J Ultrastruct Res (1974) 0.75
[3H]UTP incorporation in permeabilized mouse L-cells is inhibited by antibodies directed against a structural nuclear protein. Biochem Biophys Res Commun (1984) 0.75